Journal profile · Radiology, Nuclear Medicine & Medical Imaging
Nuclear Medicine Communications
ISSN 0143-3636 · eISSN 1473-5628 · Lippincott Williams and Wilkins Ltd. · UNITED STATES · Monthly · Founded 1980
Nuclear Medicine Communications: CAS Zone 4 · Medicine (2025 upgraded edition); impact factor 1.37; JCR Q3 (journal website); hybrid open access; median 95 days to acceptance (54 articles, last 24 months); community-reported acceptance: easy; 156 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
Nuclear Medicine Communications is published by Lippincott Williams and Wilkins Ltd. and is in Zone 4 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Medical Imaging Techniques and Applications, Radiopharmaceutical Chemistry and Applications and Cardiac Imaging and Diagnostics, together about 40.6% of its articles. Its main subfields are Radiology, Nuclear Medicine and Imaging. (generated from OpenAlex topic counts and CAS ranking data)
Apolipoprotein E (APOE) genotypes, amyloid burden, and relative cerebral perfusion surrogate provide crucial insights into Alzheimer’s disease pathophysiology. This study aimed to investigate the effects of APOE ε4 on relative perfusion and amyloid deposition in cognitively normal individuals using dual-phase 18F-florbetaben PET.
From the journal's Aims & Scope
Research area (LetPub): Radiology, Nuclear Medicine & Medical Imaging
Editor-in-chief J. BomanjiPublisher website
Main research topics OpenAlex counts of recent articles; shares are approximate
- Medical Imaging Techniques and ApplicationsMedicine21.6%
- Radiopharmaceutical Chemistry and ApplicationsMedicine11.2%
- Cardiac Imaging and DiagnosticsMedicine7.8%
- Medical Imaging and Pathology StudiesMedicine7.4%
- Radiomics and Machine Learning in Medical ImagingMedicine6.9%
- Radiation Dose and ImagingMedicine6.4%
- Advanced MRI Techniques and ApplicationsMedicine4%
- Advanced X-ray and CT ImagingEngineering3.6%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Radiology, Nuclear Medicine & Medical Imaging | Zone 4 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Radiology, Nuclear Medicine & Medical Imaging | Zone 4 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Radiology, Nuclear Medicine & Medical Imaging | Zone 4 |
Top journal: noReview journal: no
JCR / CiteScore quartiles on the journal's website
- JCR Q3 · RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING · rank 159/217
Publisher-reported: JCR figures are Clarivate's and CiteScore figures Scopus's to confirm; both are a different system from the CAS zones.Publisher website
Database indexing
SCIEScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 1.37LetPub ·
- Impact factor (publisher)
- 1.4Publisher website ·
- CiteScore 2026-06
- 2.4LetPub ·
- SJR 2026-06
- 0.4LetPub ·
- SNIP 2026-06
- 0.54LetPub ·
- h-index
- 67LetPub ·
- h-index
- 95OpenAlex ·
- i10-index
- 2,744OpenAlex ·
- 2-year mean citedness
- 1.18OpenAlex ·
- Self-citation rate
- 7.1%LetPub ·
- Share of gold OA articles
- 16.38%LetPub ·
Volume
- Articles per year
- 141LetPub ·
Articles by year OpenAlex count · 11,564 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 138 | 22 | 35 |
| 2025 | 156 | 32 | 174 |
| 2024 | 140 | 35 | 301 |
| 2023 | 147 | 33 | 576 |
| 2022 | 135 | 33 | 819 |
| 2021 | 162 | 34 | 1,123 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with Crossref · to
95 daysMedian, submission to acceptance · P25–P75 69 days – 123 days
- Acceptance to online
- median 21 days (54 articles)
- Submission to online
- median 124 days
- Sample
- 54 articles with submission and acceptance dates (337 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- 3–8 weeksLetPub ·
- Average acceptance (community reports)
- EasyLetPub ·
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Hybrid open accessLetPub
A subscription journal in which authors can pay to publish their article open access.
No source has fee information yet; check the journal's website.
A hybrid journal charges the APC only when the author chooses open access; publishing under the subscription model is usually free.
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Profile
Publication details and official links
- Publisher
- Lippincott Williams and Wilkins Ltd.
- Country or region
- UNITED STATES
- Language
- English
- Frequency
- Monthly
- Founded
- 1980
- ISSN
- 0143-3636
- Electronic ISSN
- 1473-5628
- Latest issue on the website
- Volume 47, Issue 10 (October 2026)
- Official links
- Journal homepage ↗OpenAlex
- Submission system ↗LetPub
FAQ
Frequently asked questions about Nuclear Medicine Communications
What CAS zone is Nuclear Medicine Communications in?
In the 2025 upgraded edition of the CAS Journal Ranking, Nuclear Medicine Communications is in Zone 4 of Medicine, and in Zone 4 of the minor category Radiology, Nuclear Medicine & Medical Imaging. In the 2026 Xinrui edition it is in Zone 4 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Nuclear Medicine Communications?
The latest impact factor listed by LetPub is 1.37; CiteScore 2.4, h-index 95.
How long does peer review take at Nuclear Medicine Communications?
Based on the dates recorded on 54 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 95 days (interquartile range 69–123 days); authors report an average review time of 3–8 weeks; the community-reported acceptance is “Easy”. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
What JCR quartile is Nuclear Medicine Communications in?
The journal's website gives JCR Q3; by category, RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING Q3 (159/217). JCR quartiles are Clarivate's to confirm and a different system from the CAS zones; in the CAS ranking the journal is in Zone 4 of Medicine.
Which databases index Nuclear Medicine Communications?
According to LetPub and DOAJ records, Nuclear Medicine Communications is indexed in SCIE and Scopus.
Is Nuclear Medicine Communications open access, and what is the APC?
Nuclear Medicine Communications is a hybrid journal. Fee information is not available yet; check the journal's website.
Sources and updates
The facts on this page come from LetPub, OpenAlex, Publisher website; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-24). Last updated: .